OSE Immunotherapeutics (PAR: OSE)

Last close As at 13/12/2024

EUR8.21

0.12 (1.48%)

Market capitalisation

EUR177m

OSE Immunotherapeutics (OSE) is based in Nantes and Paris in France and is listed on the Euronext Paris exchange. It is developing immunotherapies for the treatment of solid tumours and autoimmune diseases and has established several partnerships with large pharma companies.

Latest Insights

View More
OSE-Immunotherapeutics_resized

Sector

Healthcare

Equity Analyst

Arron Aatkar

Analyst

Jyoti Prakash

Jyoti Prakash

Analyst, Healthcare

Key Management

  • Dominique Costantini

    Chairman

  • Nicolas Poirier

    CEO

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free